Biotech Pioneer Enlivex Ventures into Digital Currencies

Enlivex, a company renowned for its innovative approach to immunotherapy, has secured $21 million through debt financing. This financial maneuver signals the company’s strategic venture into the realm of digital assets, particularly with the acquisition of RAIN tokens.

Continue Reading:Biotech Pioneer Enlivex Ventures into Digital Currencies